Stonybrookcme.azureedge.net



Office of Continuing Medical Education

School of Medicine/Health Sciences Center

State University of New York at Stony Brook

REFERENCE LISTS/EVIDENCE BASED MEDICINE

|Title of Program: |Dept. of Psychiatry & Behavioral Health |

|Presenter's Name: |Asif Karim, M.D. and Dhruti Patel, M.D. |

|Title of Presentation: |The Green Rush: Impacts of Marijuana Legalization on Mental Health |

|Date of Presentation: |February 18, 2020 | | |

Please provide a short list of references for your presentation including evidence based citations for practice recommendations [use additional sheet if needed].

Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Internal Medicine, 174(10), 1668-1673. doi:10.1001/jamainternmed.2014.4005

Bradford, A. C., Bradford, W.D., Abraham, A., & Bagwell Adams, G. (2018). Association between U.S. state medical cannabis laws and opioid prescribing in the Medicare Part D population. JAMA Internal Medicine, 178(5), 667-672. doi:10.1001/jamainternmed.2018.0266

Caulkins, J. P., & Kilmer, B. (2016). Considering marijuana legalization carefully: insights for other jurisdictions from analysis for Vermont. Addiction, 111(12), 2082–2089. doi: 10.1111/add.13289

Chen, Q., Larochelle, M. R., Weaver, D. T., Lietz, A. P., Mueller, P. P., Mercaldo, S., Wakeman, S. E., Freedberg, K. A., Raphel, T. J., Knudsen, A. B., Pandharipande, P. V., & Chhatwal, J. (2019). Prevention of prescription opioid misuse and projected overdose deaths in the United States. JAMA Network Open, 2(2), e187621. doi:10.1001/jamanetworkopen.2018.7621

Choo, E. K., & Emery, S. L. (2016). Clearing the haze: the complexities and challenges of research on state marijuana laws. Annals of the New York Academy of Sciences, 1394(1), 55–73. doi: 10.1111/nyas.13093

Krauss, M. J., Sowles, S. J., Mylvaganam, S., Zewdie, K., Bierut, L. J., & Cavazos-Rehg, P. A. (2015). Displays of dabbing marijuana extracts on YouTube. Drug and Alcohol Dependence, 155, 45–51. doi: 10.1016/j.drugalcdep.2015.08.020

Marel, C., Sunderland, M., Mills, K. L., Slade, T., Teesson, M., & Chapman, C. (2019). Conditional probabilities of substance use disorders and associated risk factors: Progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids. Drug and Alcohol Dependence, 194, 136–142. doi: 10.1016/j.drugalcdep.2018.10.010

New York State Department of Health. (2018). New York State Department of Health announces opioid replacement now a qualifying condition for medical marijuana. Retrieved from health.press/releases/2018/2018-07-12_opioid_replacement.htm

Pacula, R. L., & Smart, R. (2017). Medical Marijuana and Marijuana Legalization. Annual Review of Clinical Psychology, 13(1), 397–419. doi: 10.1146/annurev-clinpsy-032816-045128

Scavone, J., Sterling, R., & Bockstaele, E. V. (2013). Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal. Neuroscience, 248, 637–654. doi: 10.1016/j.neuroscience.2013.04.034

Shishko, Ilona & Oliveira, Rosana & Moore, Troy & Almeida, Kenneth. (2018). A review of medical marijuana for the treatment of posttraumatic stress disorder: Real symptom re-leaf or just high hopes?. The mental health clinician. 8. 86-94. 10.9740/mhc.2018.03.086.

Smart, R., & Pacula, R. L. (2019). Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations. The American Journal of Drug and Alcohol Abuse, 45(6), 644–663. doi: 10.1080/00952990.2019.1669626

Stoner SA. Effects of Marijuana on Mental Health: Depression. Alcohol & Drug Abuse Institute, University of Washington, June 2017. URL: .

Stoner SA. Effects of Marijuana on Mental Health: Anxiety Disorders. Alcohol & Drug Abuse Institute, University of Washington, June 2017. URL: .

Subritzky, T., Pettigrew, S., & Lenton, S. (2016). Issues in the implementation and evolution of the commercial recreational cannabis market in Colorado. International Journal of Drug Policy, 27, 1–12. doi: 10.1016/j.drugpo.2015.12.001

Substance Abuse and Mental Health Services Administration. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. Rockville, MD.

The National Academies Press. (2017). The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington, DC.

VanDolah, H.J., Bauer, B.A., and Mauck, K.F. Clinicians' guide to cannabidiol and hemp oils. Mayo Clin Proc. 2019; 94: 1840–1851

Wen, H., & Hockenberry, J. M. (2018). Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees. JAMA Internal Medicine, 178(5), 673-679. doi:10.1001/jamainternmed.2018.1007

Wen, H., Hockenberry, J. M., & Cummings, J. R. (2015). The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. Journal of Health Economics, 42, 64–80. doi: 10.1016/j.jhealeco.2015.03.007

Whiting, P. F., Wolff, R. F., Deshpande, S., Nisio, M. D., Duffy, S., Hernandez, A. V., … Kleijnen, J. (2015). Cannabinoids for Medical Use. Jama, 313(24), 2456. doi: 10.1001/jama.2015.6358

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download